Seagen (SGEN) Cash Flow Statement

Click line-items for a historical chart and %

Net income (loss)	-84.97M
Share-based compensation expense	37.05M
Depreciation and amortization	13.27M
Amortization and accretion on investments	4.32M
Deferred rent and other long-term liabilities	-855K
Interest receivable
Accounts receivable	-12.19M
Prepaid expenses and other current assets	-4.22M
Other non-current assets
Accounts payable and accrued liabilities	8.37M
Deferred revenue	-28M
Net cash provided by (used in) operating activities
Purchases of securities available for sale	-443.33M
Proceeds from maturities of securities available for sale
Purchases of property and equipment	-18.89M
Net cash used in investing activities
Net proceeds from issuance of common stock	0
Proceeds from exercise of stock options and employee stock purchase plan	23.41M
Net cash provided by financing activities
Net increase in cash and cash equivalents	28.77M
Cash and cash equivalents, at beginning of period	102.26M
Cash and cash equivalents, at end of period	131.03M

Entities mentioned with SGEN

View All Entities